Ticker Symbol | Entity Name | As Of Date | Profile Url | Name | Website | Industry | Description | Revenue | Headquarters location | CEO | Rating: CEO (%) | Rating: CEO Responses Count | Rating: Overall | Happiness: Compensation score | Happiness: Support score | Happiness: Purpose score | Happiness: Flexibility score | Happiness: Energy score | Happiness: Work Happiness score | Happiness: Trust score | Happiness: Learning score | Happiness: Belonging score | Happiness: Inclusion score | Happiness: Overall score | Happiness: Appreciation score | Happiness: Achievement score | Happiness: Responses Count | Review Count | Ratings Responses Count | Rating: Culture & Values | Rating: Compensation & Benefits | Rating: Job Security & Advancement | Rating: Senior Management | Rating: Worklife Balance | Interview: Duration Responses count | Interview Duration | Interview: Difficulty Responses count | Interview Difficulty | Interview: Experience Responses count | Interview Experience | Work Culture: Stressful (0) to Relaxed (1) Ratio | Work Culture: Slow Paced (0) to Fast Paced (1) Ratio | Work Culture: Competitive (0) to Collaborative (1) Ratio | Date Added | Date Updated | Company Name | Sector | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nasdaq:asrt | https://www.indeed.com/cmp/depomed | Aug 29th, 2022 12:00AM | Open | Depomed | Depomed, Inc. is a U.S. specialty pharmaceutical company, which mainly markets products for treatment in neurology, pain and diseases of the central nervous system. The company is a publicly traded company on NASDAQ under the symbol "DEPO", with several products approved by the U.S. Food and Drug Administration (FDA). | RRv1_100M_500M | Newark, CA | 2.70 | 27.00 | 27.00 | 2.70 | 3.40 | 2.10 | 2.70 | 3.10 | 9.00 | About two weeks | 9.00 | DIFFICULT | 9.00 | FAVORABLE | Aug 29th, 2022 11:27AM | Aug 29th, 2022 11:27AM | Assertio Therapeutics | ||||||||||||||||||||||||
nasdaq:asrt | https://www.indeed.com/cmp/assertio-therapeutics | Aug 29th, 2022 12:00AM | Open | Assertio Therapeutics | 3.30 | 4.00 | Aug 29th, 2022 11:27AM | Aug 29th, 2022 11:27AM | Assertio Therapeutics | |||||||||||||||||||||||||||||||||||||||
nasdaq:asrt | https://www.indeed.com/cmp/depomed | Aug 28th, 2022 12:00AM | Open | Depomed | Depomed, Inc. is a U.S. specialty pharmaceutical company, which mainly markets products for treatment in neurology, pain and diseases of the central nervous system. The company is a publicly traded company on NASDAQ under the symbol "DEPO", with several products approved by the U.S. Food and Drug Administration (FDA). | RRv1_100M_500M | Newark, CA | 2.70 | 27.00 | 27.00 | 2.70 | 3.40 | 2.10 | 2.70 | 3.10 | 9.00 | About two weeks | 9.00 | DIFFICULT | 9.00 | FAVORABLE | Aug 28th, 2022 04:26AM | Aug 28th, 2022 04:26AM | Assertio Therapeutics | ||||||||||||||||||||||||
nasdaq:asrt | https://www.indeed.com/cmp/assertio-therapeutics | Aug 28th, 2022 12:00AM | Open | Assertio Therapeutics | 3.30 | 4.00 | Aug 28th, 2022 04:26AM | Aug 28th, 2022 04:26AM | Assertio Therapeutics | |||||||||||||||||||||||||||||||||||||||
nasdaq:asrt | https://www.indeed.com/cmp/assertio-therapeutics | Aug 27th, 2022 12:00AM | Open | Assertio Therapeutics | 3.30 | 4.00 | Aug 27th, 2022 03:46AM | Aug 27th, 2022 03:46AM | Assertio Therapeutics | |||||||||||||||||||||||||||||||||||||||
nasdaq:asrt | https://www.indeed.com/cmp/depomed | Aug 27th, 2022 12:00AM | Open | Depomed | Depomed, Inc. is a U.S. specialty pharmaceutical company, which mainly markets products for treatment in neurology, pain and diseases of the central nervous system. The company is a publicly traded company on NASDAQ under the symbol "DEPO", with several products approved by the U.S. Food and Drug Administration (FDA). | RRv1_100M_500M | Newark, CA | 2.70 | 27.00 | 27.00 | 2.70 | 3.40 | 2.10 | 2.70 | 3.10 | 9.00 | About two weeks | 9.00 | DIFFICULT | 9.00 | FAVORABLE | Aug 27th, 2022 03:46AM | Aug 27th, 2022 03:46AM | Assertio Therapeutics | ||||||||||||||||||||||||
nasdaq:asrt | https://www.indeed.com/cmp/assertio-therapeutics | Aug 25th, 2022 12:00AM | Open | Assertio Therapeutics | 3.30 | 4.00 | Aug 25th, 2022 08:26AM | Aug 25th, 2022 08:26AM | Assertio Therapeutics | |||||||||||||||||||||||||||||||||||||||
nasdaq:asrt | https://www.indeed.com/cmp/depomed | Aug 25th, 2022 12:00AM | Open | Depomed | Depomed, Inc. is a U.S. specialty pharmaceutical company, which mainly markets products for treatment in neurology, pain and diseases of the central nervous system. The company is a publicly traded company on NASDAQ under the symbol "DEPO", with several products approved by the U.S. Food and Drug Administration (FDA). | RRv1_100M_500M | Newark, CA | 2.70 | 27.00 | 27.00 | 2.70 | 3.40 | 2.10 | 2.70 | 3.10 | 9.00 | About two weeks | 9.00 | DIFFICULT | 9.00 | FAVORABLE | Aug 25th, 2022 08:26AM | Aug 25th, 2022 08:26AM | Assertio Therapeutics | ||||||||||||||||||||||||
nasdaq:asrt | https://www.indeed.com/cmp/depomed | Aug 23rd, 2022 12:00AM | Open | Depomed | Depomed, Inc. is a U.S. specialty pharmaceutical company, which mainly markets products for treatment in neurology, pain and diseases of the central nervous system. The company is a publicly traded company on NASDAQ under the symbol "DEPO", with several products approved by the U.S. Food and Drug Administration (FDA). | RRv1_100M_500M | Newark, CA | 2.70 | 27.00 | 27.00 | 2.70 | 3.40 | 2.10 | 2.70 | 3.10 | 9.00 | About two weeks | 9.00 | DIFFICULT | 9.00 | FAVORABLE | Aug 23rd, 2022 10:19AM | Aug 23rd, 2022 10:19AM | Assertio Therapeutics | ||||||||||||||||||||||||
nasdaq:asrt | https://www.indeed.com/cmp/assertio-therapeutics | Aug 23rd, 2022 12:00AM | Open | Assertio Therapeutics | 3.30 | 4.00 | Aug 23rd, 2022 10:19AM | Aug 23rd, 2022 10:19AM | Assertio Therapeutics |